trending Market Intelligence /marketintelligence/en/news-insights/trending/U-ugGCfnXLdT1_1bOnTEIw2 content esgSubNav
In This List

ContraVir Pharmaceuticals chief medical officer steps down

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


ContraVir Pharmaceuticals chief medical officer steps down

ContraVir Pharmaceuticals Inc. said John Sullivan-Bolyai is stepping down as chief medical officer and taking on a new role in the company, effective Dec. 29.

Sullivan-Bolyai will serve as a part-time consultant to the company, where he will remain involved in strategic decisions as well as medical and clinical affairs.